Synopsis
Synopsis
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 2 Bromo Alpha Ergocryptine
2. 2 Bromo Alpha Ergokryptine
3. 2 Bromoergocryptine
4. 2 Bromoergocryptine Mesylate
5. 2 Bromoergocryptine Methanesulfonate
6. 2 Bromoergokryptine
7. 2-bromo-alpha-ergocryptine
8. 2-bromo-alpha-ergokryptine
9. 2-bromoergocryptine
10. 2-bromoergocryptine Mesylate
11. 2-bromoergocryptine Methanesulfonate
12. 2-bromoergokryptine
13. Bromocriptin
14. Bromocriptine
15. Bromocryptin
16. Cb 154
17. Cb-154
18. Cb154
19. Mesylate, 2-bromoergocryptine
20. Mesylate, Bromocriptine
21. Methanesulfonate, 2-bromoergocryptine
22. Parlodel
1. 22260-51-1
2. Parlodel
3. Bromocriptine Mesilate
4. Bromocryptine Mesylate
5. Pravidel
6. Bromocriptine Methanesulfonate
7. Cycloset
8. Bagren
9. Cb-154 Mesylate
10. Bromergon
11. (+)-bromocriptine Methanesulfonate
12. 2-bromo-alpha-ergocryptine Mesylate
13. Cb-154
14. Cb-154 Mesilate
15. Cb 154
16. 2-bromoergocryptine Monomethanesulfonate (salt)
17. Ffp983j3od
18. Bromocriptine (mesylate)
19. Chebi:3182
20. 2-bromoergocryptine Mesylate
21. Nsc-755915
22. Oline-9-carboxamide Methanesulfonate
23. Bromocryptine Methanesulfonate
24. (5'a)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione Mesylate
25. Bromocriptine Mesylate [usan]
26. Nsc169774
27. Sr-01000597796
28. Einecs 244-881-1
29. Unii-ffp983j3od
30. 2-bromo-alpha-ergocryptine Methanesulfonate
31. Sr-01000075356
32. 2-bromine-alpha-ergocryptine Methanesulfonate
33. 2-bromo-alpha-ergokryptine-mesilate [german]
34. Bromocriptine Mesylate [usan:usp]
35. Parlodel (tn)
36. (5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)ergotaman Methanesulfonate (salt)
37. (6ar,9r)-5-bromo-n-[(2r,5s,10as,10bs)-10b-hydroxy-2-(1-methylethyl)-5-(2-methylpropyl)-3,6-dioxooctahydro-8h-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quin
38. 2-bromo-alpha-ergokryptine-mesilate
39. Prestwick_771
40. Cas-22260-51-1
41. Dsstox_cid_197
42. Bromocriptinemesylate
43. Alpha-ergocryptine, 2-bromo-, Methanesulfonate
44. Dsstox_rid_75426
45. Dsstox_gsid_20197
46. Schembl40559
47. 2-bromo-12'-hydroxy-5'alpha-isobutyl-2'-isopropylergotaman-3',6',18-trione Monomethanesulphonate
48. Bromocriptine Mesylate (usp)
49. Bromocriptine Mesylate- Bio-x
50. Bromocriptine Mesilate (jp17)
51. Chembl1200503
52. Dtxsid6020197
53. 2-bromo ?-ergocryptine Mesylate
54. Cb 154 Methanesulfonate (salt)
55. C32h40brn5o5.ch3so3h
56. Hms1568i04
57. Hms3260d03
58. Hms3411k09
59. Hms3675k09
60. Hms3712i04
61. 2-bromo Alpha-ergocryptine Mesylate
62. Bromocriptine Mesilate [jan]
63. Tox21_303597
64. Tox21_500171
65. Hy-12705a
66. Bromocriptine Mesylate [vandf]
67. .alpha.-ergocryptine, Methanesulfonate
68. Akos015896276
69. Bromocriptine Mesilate [mart.]
70. Bromocriptine Mesilate [who-dd]
71. Bromocriptine Mesylate [usp-rs]
72. Ccg-220121
73. Ccg-221475
74. Cs-6048
75. Lp00171
76. Nsc 755915
77. Nsc-169774
78. Ncgc00257268-01
79. Ncgc00260856-01
80. Bb164266
81. Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, Monomethanesulfonate (salt), (5'alpha)-
82. Bromocriptine Methanesulfonate [mi]
83. Bromocriptine Mesylate [orange Book]
84. 2-bromo-a-ergocryptine Methanesulfonate Salt
85. B6298
86. Bromocriptine Mesilate [ep Monograph]
87. Eu-0100171
88. Bromocriptine Mesylate [usp Monograph]
89. B 2134
90. D00780
91. D81822
92. 2-bromo-.alpha.-ergocryptine Monomethanesulfonate
93. A903911
94. Sr-01000075356-1
95. Sr-01000597796-1
96. Sr-01000597796-2
97. Q27105974
98. 2-bromoergocryptine Monomethanesulphonate (salt)
99. (+)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6'-18-trione Methanesulfonate Salt
100. (5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman Methanesulfonate
101. (5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman Methanesulfonate
102. (6ar,9r)-5-bromo-n-[(1s,2s,4r,7s)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4h-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic Acid
103. Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5.alpha.)-, Methanesulfonate (1:1)
104. Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, Monomethanesulfonate (salt), (5'.alpha.)-
105. Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, Monomethanesulphonate (salt), (5'.alpha.)-
Molecular Weight | 750.7 g/mol |
---|---|
Molecular Formula | C33H44BrN5O8S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 5 |
Exact Mass | 749.20940 g/mol |
Monoisotopic Mass | 749.20940 g/mol |
Topological Polar Surface Area | 181 Ų |
Heavy Atom Count | 48 |
Formal Charge | 0 |
Complexity | 1320 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Bromocriptine mesylate |
Drug Label | Bromocriptine mesylate is an ergot derivative with potent dopamine receptor agonist activity. Each bromocriptine mesylate tablet, USP for oral administration contains 2.5 mg bromocriptine (as the mesylate). Bromocriptine mesylate is chemically design... |
Active Ingredient | Bromocriptine mesylate |
Dosage Form | Tablet; Capsule |
Route | Oral |
Strength | eq 5mg base; eq 2.5mg base |
Market Status | Prescription |
Company | Lek Pharms; Paddock; Zydus Pharms Usa; Mylan |
2 of 6 | |
---|---|
Drug Name | Cycloset |
PubMed Health | Bromocriptine (By mouth) |
Drug Classes | Antidiabetic, Antiparkinsonian, Prolactin Secretion Inhibitor |
Drug Label | CYCLOSET Tablets contain bromocriptine mesylate, a dopamine receptor agonist. Bromocriptine mesylate is chemically designated [Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, monomethanesulf |
Active Ingredient | Bromocriptine mesylate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 0.8mg base |
Market Status | Prescription |
Company | Veroscience |
3 of 6 | |
---|---|
Drug Name | Parlodel |
PubMed Health | Bromocriptine (By mouth) |
Drug Classes | Antidiabetic, Antiparkinsonian, Prolactin Secretion Inhibitor |
Drug Label | Parlodel (bromocriptine mesylate) is an ergot derivative with potent dopamine receptor agonist activity. Each Parlodel (bromocriptine mesylate) SnapTabs tablet for oral administration contains 2 mg and each capsule contains 5 mg bromocriptine... |
Active Ingredient | Bromocriptine mesylate |
Dosage Form | Tablet; Capsule |
Route | Oral |
Strength | eq 5mg base; eq 2.5mg base |
Market Status | Prescription |
Company | Us Pharms Holdings I |
4 of 6 | |
---|---|
Drug Name | Bromocriptine mesylate |
Drug Label | Bromocriptine mesylate is an ergot derivative with potent dopamine receptor agonist activity. Each bromocriptine mesylate tablet, USP for oral administration contains 2.5 mg bromocriptine (as the mesylate). Bromocriptine mesylate is chemically design... |
Active Ingredient | Bromocriptine mesylate |
Dosage Form | Tablet; Capsule |
Route | Oral |
Strength | eq 5mg base; eq 2.5mg base |
Market Status | Prescription |
Company | Lek Pharms; Paddock; Zydus Pharms Usa; Mylan |
5 of 6 | |
---|---|
Drug Name | Cycloset |
PubMed Health | Bromocriptine (By mouth) |
Drug Classes | Antidiabetic, Antiparkinsonian, Prolactin Secretion Inhibitor |
Drug Label | CYCLOSET Tablets contain bromocriptine mesylate, a dopamine receptor agonist. Bromocriptine mesylate is chemically designated [Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, monomethanesulf |
Active Ingredient | Bromocriptine mesylate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 0.8mg base |
Market Status | Prescription |
Company | Veroscience |
6 of 6 | |
---|---|
Drug Name | Parlodel |
PubMed Health | Bromocriptine (By mouth) |
Drug Classes | Antidiabetic, Antiparkinsonian, Prolactin Secretion Inhibitor |
Drug Label | Parlodel (bromocriptine mesylate) is an ergot derivative with potent dopamine receptor agonist activity. Each Parlodel (bromocriptine mesylate) SnapTabs tablet for oral administration contains 2 mg and each capsule contains 5 mg bromocriptine... |
Active Ingredient | Bromocriptine mesylate |
Dosage Form | Tablet; Capsule |
Route | Oral |
Strength | eq 5mg base; eq 2.5mg base |
Market Status | Prescription |
Company | Us Pharms Holdings I |
Antiparkinson Agents
Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)
Hormone Antagonists
Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)
Dopamine Agonists
Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)
GDUFA
DMF Review : Complete
Rev. Date : 2012-11-30
Pay. Date : 2012-11-13
DMF Number : 14768
Submission : 2000-03-03
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6955
Submission : 1987-05-11
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11973
Submission : 1996-05-06
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6737
Submission : 1986-12-16
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7088
Submission : 1987-07-24
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6827
Submission : 1987-02-13
Status : Active
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6984
Submission : 1987-05-08
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Certificate Number : CEP 2006-281 - Rev 03
Status : Valid
Issue Date : 2024-02-05
Type : Chemical
Substance Number : 596
Certificate Number : R1-CEP 2000-151 - Rev 07
Status : Valid
Issue Date : 2021-08-05
Type : Chemical
Substance Number : 596
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?